S&W Seed Company to Report Third Quarter Fiscal Year 2021 Financial Results on Thursday, May 13, 2021
Conference call to be conducted on Thursday, May 13, 2021 at 11:00 am ET
News provided by
Share this article
Share this article
LONGMONT, Colo., May 5, 2021 /PRNewswire/ S&W Seed Company (Nasdaq: SANW) will report financial results for its third quarter of fiscal year 2021, ended March 31, 2021 on Thursday, May 13, 2021 before the open of the market. The Company has scheduled a conference call that same day, Thursday, May 13, 2021, at 11:00 am ET, to review the results.
Interested parties can access the conference call by dialing (844) 861-5498 or (412) 317-6580 or can listen via a live Internet webcast, which is available in the Investor Relations section of the Company s website at http://www.swseedco.com/investors.
LiqTech International to Discuss First Quarter 2021 Results on Wednesday, May 12, 2021
Management to Host Conference Call on Wednesday, May 12, 2021 at 9:00 a.m. ET
News provided by
Share this article
BALLERUP, Denmark, May 3, 2021 /PRNewswire/
LiqTech International, Inc. (NASDAQ: LIQT), a clean technology company that manufactures and markets highly specialized filtration products and systems, will report financial results for its first quarter 2021 ended March 31, 2021 on Wednesday, May 12, 2021 before the market opens. The Company has scheduled a conference call that same day, Wednesday, May 12, 2021 at 9:00 a.m. ET, to review the results.
First Quarter 2021 Conference Call Details
Date and Time: Wednesday, May 12, 2021 at 9:00 a.m. ET
Boston biotech leaders sign letter against voter suppression - San Francisco Business Times bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
ImmuCell Closes $4,250,000 Equity Financing
ImmuCell CorporationApril 14, 2021 GMT
PORTLAND, Maine, April 14, 2021 (GLOBE NEWSWIRE) ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, today announced that it has closed an equity investment.
On April 14, 2021, the Company issued the aggregate of 515,156 common shares at $8.25 per share directly to its largest stockholder (the Pessin family) and several other investors, raising gross proceeds of $4,250,037, with minimal closing costs. These shares have been registered under the Company’s effective shelf registration statement on Form S-3.
LiqTech International to Present at the Lytham Partners Spring 2021 Investor Conference apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.